{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:35:28Z","timestamp":1793946928135,"version":"4.8.0"},"reference-count":184,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The incidence of inflammatory bowel disease [IBD] is rising most rapidly among children and adolescents. Paediatric-onset IBD is associated with a more extensive and severe disease course compared to adult-onset IBD. At a young age, screening for underlying genetic and immunological disorders is important and may impact treatment management. Early and effective treatment is crucial to reach disease remission and prevent complications of ongoing active disease. In children with Crohn\u2019s disease, exclusive enteral nutrition is an effective induction therapy. Other promising dietary therapies, such as the Crohn\u2019s disease exclusion diet, are emerging. Within paediatric IBD, anti-tumour necrosis factor therapy is the only approved biological thus far and additional treatment options are crucially needed. Other biological therapies, such as vedolizumab and ustekinumab, are currently prescribed off-label in this population. A specific challenge in paediatric IBD is the unacceptable and major delay in approval of drugs for children with IBD. A guided transfer period of paediatric patients to adult care is associated with improved disease outcomes and is required. Major knowledge gaps and challenges within paediatric IBD include the aetiology, diagnostics, and monitoring of disease, tailoring of treatment, and both understanding and coping with the physical and psychological consequences of living with IBD. Challenges and research gaps in paediatrics should be addressed without any delay in comparison with the adult field, in order to ensure a high quality of care for all patients with IBD, irrespective of the age of onset.<\/jats:p>","DOI":"10.1093\/ecco-jcc\/jjae087","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:30:03Z","timestamp":1718130603000},"page":"ii31-ii45","source":"Crossref","is-referenced-by-count":46,"title":["Considerations in Paediatric and Adolescent Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2710-7241","authenticated-orcid":false,"given":"Stephanie A","family":"Vuijk","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Erasmus MC \u2013 Sophia Children\u2019s Hospital , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2846-4207","authenticated-orcid":false,"given":"Anouk E","family":"Camman","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, Erasmus MC \u2013 Sophia Children\u2019s Hospital , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6035-1182","authenticated-orcid":false,"given":"Lissy","family":"de Ridder","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology, Erasmus MC \u2013 Sophia Children\u2019s Hospital , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"2024103011391113500_CIT0001","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"2024103011391113500_CIT0002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1067\/S0022-3476(03)00444-X","article-title":"Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study","volume":"143","author":"Kugathasan","year":"2003","journal-title":"J Pediatr"},{"key":"2024103011391113500_CIT0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ajg.2017.228","article-title":"Dramatic increase in incidence of ulcerative colitis and Crohn\u2019s disease (1988\u20132011): a population-based study of French adolescents","volume":"113","author":"Ghione","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2024103011391113500_CIT0004","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gtc.2023.05.001","article-title":"Epidemiology of pediatric inflammatory bowel disease","volume":"52","author":"Khan","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"key":"2024103011391113500_CIT0005","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2021.12.282","article-title":"Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review","volume":"162","author":"Kuenzig","year":"2022","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0006","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"2024103011391113500_CIT0007","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/ibd.21591","article-title":"Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994\u20132007)","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0008","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/jcag\/gwy056","article-title":"The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD","volume":"2","author":"Carroll","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"2024103011391113500_CIT0009","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.molmet.2016.07.007","article-title":"The changing microbial landscape of Western society: Diet, dwellings and discordance","volume":"5","author":"Broussard","year":"2016","journal-title":"Mol Metab"},{"key":"2024103011391113500_CIT0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2024103011391113500_CIT0011","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/advances\/nmaa145","article-title":"Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: a systematic review and meta-analysis","volume":"12","author":"Milajerdi","year":"2021","journal-title":"Adv Nutr"},{"key":"2024103011391113500_CIT0012","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.14291","article-title":"Systematic review with meta-analysis: breastfeeding and the risk of Crohn\u2019s disease and ulcerative colitis","volume":"46","author":"Xu","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0013","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"10","author":"Singh","year":"2022","journal-title":"United European Gastroenterology J"},{"key":"2024103011391113500_CIT0014","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/17474124.2018.1511425","article-title":"Urban\u2013rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis","volume":"13","author":"Song","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.gtc.2023.05.011","article-title":"The role of diet in pediatric inflammatory bowel disease","volume":"52","author":"Albenberg","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"key":"2024103011391113500_CIT0016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ecco-jcc\/jjac105","article-title":"Successful dietary therapy in Paediatric Crohn\u2019s disease is associated with shifts in bacterial dysbiosis and inflammatory metabotype towards healthy controls","volume":"17","author":"Verburgt","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2036.2000.00707.x","article-title":"Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn\u2019s disease","volume":"14","author":"Fell","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0018","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/ajg.2010.252","article-title":"The inflammatory bowel diseases and ambient air pollution: a novel association","volume":"105","author":"Kaplan","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2024103011391113500_CIT0019","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/jcag\/gwad016","article-title":"The 2023 impact of inflammatory bowel disease in Canada: special populations\u2014children and adolescents with IBD","volume":"6","author":"El-Matary","year":"2023","journal-title":"J Can Assoc Gastroenterol"},{"key":"2024103011391113500_CIT0020","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults","volume":"135","author":"Kappelman","year":"2008","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izz104","article-title":"The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation","volume":"26","author":"Park","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0022","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ibd\/izz120","article-title":"Disease-associated costs in children with inflammatory bowel disease: a systematic review","volume":"26","author":"El-Matary","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0023","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/jcag\/gwy050","article-title":"The impact of inflammatory bowel disease in Canada 2018: indirect costs of IBD care","volume":"2","author":"Kuenzig","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"2024103011391113500_CIT0024","doi-asserted-by":"crossref","first-page":"58","DOI":"10.33590\/emjgastroenterol\/10312720","article-title":"Making the invisible visible: the hidden cost of paediatric inflammatory bowel disease","volume":"8","author":"Turner","year":"2019","journal-title":"EMJ Gastroenterology"},{"key":"2024103011391113500_CIT0025","first-page":"1368","article-title":"Out-of-pocket cost burden in pediatric inflammatory bowel disease: a cross-sectional cohort analysis","volume":"21","author":"Sin","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0026","doi-asserted-by":"crossref","first-page":"577677","DOI":"10.3389\/fimmu.2020.577677","article-title":"Current developments of clinical sequencing and the clinical utility of polygenic risk scores in inflammatory diseases","volume":"11","author":"H\u00fcbenthal","year":"2021","journal-title":"Front Immunol"},{"key":"2024103011391113500_CIT0027","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","article-title":"The diagnostic approach to monogenic very early onset inflammatory bowel disease","volume":"147","author":"Uhlig","year":"2014","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0028","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tig.2017.06.008","article-title":"Clinical genomics in inflammatory bowel disease","volume":"33","author":"Uhlig","year":"2017","journal-title":"Trends Genet"},{"key":"2024103011391113500_CIT0029","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1053\/j.gastro.2021.11.014","article-title":"An integrated taxonomy for monogenic inflammatory bowel disease","volume":"162","author":"Bolton","year":"2022","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0030","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MPG.0000000000003017","article-title":"Clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease: a position paper from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"72","author":"Uhlig","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0031","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41467-019-14275-y","article-title":"Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease","volume":"11","author":"Serra","year":"2020","journal-title":"Nat Commun"},{"key":"2024103011391113500_CIT0032","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/MIB.0000000000001246","article-title":"Genetic and transcriptomic bases of intestinal epithelial barrier dysfunction in inflammatory bowel disease","volume":"23","author":"Vancamelbeke","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0033","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ibd\/izac217","article-title":"Aberrant mucin expression profiles associate with pediatric inflammatory bowel disease presentation and activity","volume":"29","author":"Breugelmans","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0034","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10875-014-9992-8","article-title":"Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation","volume":"34","author":"Murugan","year":"2014","journal-title":"J Clin Immunol"},{"key":"2024103011391113500_CIT0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2012.04.045","article-title":"Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy","volume":"143","author":"Kotlarz","year":"2012","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0036","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"key":"2024103011391113500_CIT0037","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/gutjnl-2013-306520","article-title":"XIAP variants in male Crohn\u2019s disease","volume":"64","author":"Zeissig","year":"2014","journal-title":"Gut"},{"key":"2024103011391113500_CIT0038","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1053\/j.gastro.2018.02.028","article-title":"Analysis of genes associated with monogenic primary immunodeficiency identifies rare variants in XIAP in patients with Crohn\u2019s disease","volume":"154","author":"Amininejad","year":"2018","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0039","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00439-022-02464-7","article-title":"Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice","volume":"142","author":"Azabdaftari","year":"2023","journal-title":"Hum Genet"},{"key":"2024103011391113500_CIT0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","article-title":"Clinical outcome in IL-10\u2013 and IL-10 receptor\u2013deficient patients with or without hematopoietic stem cell transplantation","volume":"131","author":"Engelhardt","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2024103011391113500_CIT0041","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory bowel disease in children and adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2024103011391113500_CIT0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.32074\/1591-951X-336","article-title":"Very early onset-IBD: evidence for the need of a multidisciplinary approach","volume":"114","author":"Parente","year":"2022","journal-title":"Pathologica"},{"key":"2024103011391113500_CIT0043","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bpg.2004.01.002","article-title":"Specificities of inflammatory bowel disease in childhood","volume":"18","author":"Griffiths","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2024103011391113500_CIT0044","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/gut.34.7.939","article-title":"Growth and clinical course of children with Crohn\u2019s disease","volume":"34","author":"Griffiths","year":"1993","journal-title":"Gut"},{"key":"2024103011391113500_CIT0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpeds.2022.05.041","article-title":"Sex-specific pathways lead to statural growth impairment in children with Crohn\u2019s disease","volume":"249","author":"Gupta","year":"2022","journal-title":"J Pediatr"},{"key":"2024103011391113500_CIT0046","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0000000000003670","article-title":"Systematic review of diagnostic delay for children with inflammatory bowel disease","volume":"76","author":"Vernon-Roberts","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0047","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.crohns.2014.05.008","article-title":"Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis","volume":"8","author":"Childers","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0048","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00431-021-04269-8","article-title":"Increasing rate of a positive family history of inflammatory bowel disease (IBD) in pediatric IBD patients","volume":"181","author":"Ruban","year":"2022","journal-title":"Eur J Pediatr"},{"key":"2024103011391113500_CIT0049","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/MPG.0000000000002253","article-title":"Change in prevalence of family history during long-term follow-up of patients with pediatric-onset inflammatory bowel disease","volume":"68","author":"Capone","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/apt.16938","article-title":"Age determines the risk of familial inflammatory bowel disease\u2014a nationwide study","volume":"56","author":"Halfvarson","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0051","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ecco-jcc\/jjz106","article-title":"Phenotypic variation in paediatric inflammatory bowel disease by age: a multicentre prospective inception cohort study of the Canadian children IBD network","volume":"14","author":"Dhaliwal","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0052","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ibd.21152","article-title":"Natural history of Crohn\u2019s disease: comparison between childhood- and adult-onset disease","volume":"16","author":"Pigneur","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0053","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","article-title":"Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease","volume":"135","author":"Van Limbergen","year":"2008","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0054","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/MPG.0b013e31829f7d8c","article-title":"Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease","volume":"57","author":"M\u00fcller","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2020.07.065","article-title":"Predicting outcomes in pediatric crohn\u2019s disease for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease\u2013ahead program","volume":"160","author":"Ricciuto","year":"2021","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0056","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrgastro.2009.124","article-title":"Mechanisms of growth impairment in pediatric Crohn\u2019s disease","volume":"6","author":"Walters","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-021-02496-4","article-title":"Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease","volume":"21","author":"Jin","year":"2021","journal-title":"BMC Pediatr"},{"key":"2024103011391113500_CIT0058","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/ibd\/izy026","article-title":"School functioning in adolescents with inflammatory bowel diseases: an examination of disease and demographic correlates","volume":"24","author":"Carreon","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0059","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/MPG.0000000000003905","article-title":"Fatigue and physical activity patterns in children with inflammatory bowel disease","volume":"77","author":"Bevers","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MPG.0b013e3182841263","article-title":"Psychosocial issues in pediatric inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition","volume":"56","author":"Mackner","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0061","first-page":"izad169","article-title":"Children and young adults with inflammatory bowel disease have an increased incidence and risk of developing mental health conditions: a UK population-based cohort study","author":"Cooney","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0062","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MPG.0b013e31822f2c32","article-title":"Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease","volume":"53","author":"Ross","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0063","doi-asserted-by":"crossref","first-page":"110354","DOI":"10.1016\/j.jpsychores.2020.110354","article-title":"Determinants of quality of life and psychosocial adjustment to pediatric inflammatory bowel disease: a systematic review focused on Crohn\u2019s disease","volume":"142","author":"Touma","year":"2021","journal-title":"J Psychosom Res"},{"key":"2024103011391113500_CIT0064","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpeds.2022.04.014","article-title":"High impact of pediatric inflammatory bowel disease on caregivers\u2019 work productivity and daily activities: an international prospective study","volume":"246","author":"Klomberg","year":"2022","journal-title":"J Pediatr"},{"key":"2024103011391113500_CIT0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5223\/pghn.2019.22.6.527","article-title":"Burden of psychiatric disorders among pediatric and young adults with inflammatory bowel disease: a population-based analysis","volume":"22","author":"Thavamani","year":"2019","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"2024103011391113500_CIT0066","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/DBP.0b013e318290568a","article-title":"Parenting stress in pediatric IBD: relations with child psychopathology, family functioning, and disease severity","volume":"34","author":"Gray","year":"2013","journal-title":"J Dev Behav Pediatr"},{"key":"2024103011391113500_CIT0067","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0068","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The medical management of paediatric Crohn\u2019s disease: an ECCO-ESPGHAN guideline update","volume":"15","author":"van Rheenen","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0069","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0000000000002035","article-title":"Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn\u2019s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MPG.0b013e318235b397","article-title":"Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease","volume":"54","author":"Critch","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0071","first-page":"464","article-title":"Consensus and controversy in the management of pediatric Crohn disease: an international survey","volume":"36","author":"Levine","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0072","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181e2c724","article-title":"Physician attitudes and practices of enteral nutrition as primary treatment of paediatric Crohn disease in North America","volume":"52","author":"Stewart","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0073","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MPG.0000000000001896","article-title":"Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition","volume":"66","author":"Miele","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0074","first-page":"CD012839","article-title":"Dietary interventions for induction and maintenance of remission in inflammatory bowel disease","volume":"2","author":"Limketkai","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2024103011391113500_CIT0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MPG.0000000000001785","article-title":"Reasoning beyond the potential use of exclusive enteral nutrition and other specified diets in children with ulcerative colitis","volume":"66","author":"Shaoul","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0076","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/apt.12770","article-title":"Repeated exclusive enteral nutrition in the treatment of paediatric Crohn\u2019s disease: predictors of efficacy and outcome","volume":"39","author":"Frivolt","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0077","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ecco-jcc\/jjx150","article-title":"Differences in outcomes over time with exclusive enteral nutrition compared with steroids in children with mild to moderate Crohn\u2019s disease: results from the GROWTH CD study","volume":"12","author":"Cohen-Dolev","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0078","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.14253","article-title":"Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn\u2019s disease","volume":"46","author":"Swaminath","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0079","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00535-009-0165-0","article-title":"Effect of exclusive enteral nutrition on bone turnover in children with Crohn\u2019s disease","volume":"45","author":"Whitten","year":"2010","journal-title":"J Gastroenterol"},{"key":"2024103011391113500_CIT0080","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ecco-jcc\/jjx060","article-title":"Exclusive enteral nutrition therapy in paediatric Crohn\u2019s disease results in long-term avoidance of corticosteroids: results of a propensity-score matched cohort analysis","volume":"11","author":"Connors","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0081","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.crohns.2012.07.001","article-title":"Use of exclusive enteral nutrition in paediatric Crohn\u2019s disease in The Netherlands","volume":"7","author":"de Bie","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0082","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MPG.0b013e3181e712d6","article-title":"Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease","volume":"51","author":"Akobeng","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0083","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5223\/pghn.2023.26.3.165","article-title":"Exclusive enteral nutrition for the treatment of pediatric Crohn\u2019s disease: the patient perspective","volume":"26","author":"Brown","year":"2023","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"2024103011391113500_CIT0084","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MPG.0000000000002847","article-title":"Parent perspectives on exclusive enteral nutrition for the treatment of pediatric Crohn disease","volume":"71","author":"Mehta","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0085","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.cgh.2020.04.006","article-title":"Dietary therapies induce rapid response and remission in pediatric patients with active Crohn\u2019s disease","volume":"19","author":"Boneh","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0086","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/ibd\/izac215","article-title":"Induction of remission with exclusive enteral nutrition in children with Crohn\u2019s disease: determinants of higher adherence and response","volume":"29","author":"Cuomo","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0087","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jpn3.12096","article-title":"Precision nutrition in pediatric IBD: a position paper from the ESPGHAN special interest group for basic science and translational research, the IBD Porto group, and allied health professionals","volume":"78","author":"Gerasimidis","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0088","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review","volume":"166","author":"Hashash","year":"2024","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0089","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/nu12041012","article-title":"Predictors of response to exclusive enteral nutrition in newly diagnosed Crohn\u2019s disease in children: PRESENCE study from SEGHNP","volume":"12","author":"Moriczi","year":"2020","journal-title":"Nutrients"},{"key":"2024103011391113500_CIT0090","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10620-005-2864-6","article-title":"Colonic Crohn\u2019s disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved","volume":"50","author":"Afzal","year":"2005","journal-title":"Dig Dis Sci"},{"key":"2024103011391113500_CIT0091","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1365-2036.2011.04662.x","article-title":"The efficacy of exclusive nutritional therapy in paediatric Crohn\u2019s disease, comparing fractionated oral vs. continuous enteral feeding","volume":"33","author":"Rubio","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0092","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2036.2009.04067.x","article-title":"The use of exclusive enteral nutrition for induction of remission in children with Crohn\u2019s disease demonstrates that disease phenotype does not influence clinical remission","volume":"30","author":"Buchanan","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0093","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archsurg.1973.01350200189039","article-title":"Experience with elemental diet in the treatment of inflammatory bowel disease: is this primary therapy","volume":"107","author":"Voitk","year":"1973","journal-title":"Arch Surg"},{"key":"2024103011391113500_CIT0094","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MOG.0b013e328339536b","article-title":"The intestinal microbiota in inflammatory bowel diseases: time to connect with the host","volume":"26","author":"Sokol","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"2024103011391113500_CIT0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","article-title":"Crohn\u2019s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial","volume":"157","author":"Levine","year":"2019","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0096","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/apt.17451","article-title":"Review article: mechanisms underlying the effectiveness of exclusive enteral nutrition in Crohn\u2019s disease","volume":"57","author":"Melton","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0097","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2036.1995.tb00419.x","article-title":"The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn\u2019s disease","volume":"9","author":"Breese","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0098","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.MIB.0000161307.58327.96","article-title":"Impact of elemental diet on mucosal inflammation in patients with active Crohn\u2019s disease: cytokine production and endoscopic and histological findings","volume":"11","author":"Yamamoto","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0099","first-page":"270","article-title":"Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease","volume":"38","author":"Bannerjee","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaci.2015.12.1331","article-title":"Exclusive enteral nutrition in active pediatric Crohn disease: Effects on intestinal microbiota and immune regulation","volume":"138","author":"Schwerd","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2024103011391113500_CIT0101","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/archdischild-2020-320875","article-title":"Microbiome and paediatric gut diseases","volume":"107","author":"Gerasimidis","year":"2022","journal-title":"Arch Dis Child"},{"key":"2024103011391113500_CIT0102","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/nu9080832","article-title":"Effects of the exclusive enteral nutrition on the microbiota profile of patients with Crohn\u2019s disease: a systematic review","volume":"9","author":"Gatti","year":"2017","journal-title":"Nutrients"},{"key":"2024103011391113500_CIT0103","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1590-8658(00)80353-9","article-title":"Oral nutritional supplementation is effective in the maintenance of remission in Crohn\u2019s disease","volume":"32","author":"Verma","year":"2000","journal-title":"Dig Liver Dis"},{"key":"2024103011391113500_CIT0104","first-page":"2882","article-title":"Long-term efficacy of low residue diet for the maintenance of remission in patients with Crohn\u2019s disease","volume":"90","author":"Koga","year":"1993","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"2024103011391113500_CIT0105","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/MIB.0000000000000110","article-title":"Partial enteral nutrition with a Crohn\u2019s disease exclusion diet is effective for induction of remission in children and young adults with Crohn\u2019s disease","volume":"20","author":"Sigall-Boneh","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0106","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00431-019-03520-7","article-title":"Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn\u2019s disease: Results of a prospective cohort study","volume":"179","author":"Urlep","year":"2020","journal-title":"Eur J Pediatr"},{"key":"2024103011391113500_CIT0107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-13-5","article-title":"An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report","volume":"13","author":"Olendzki","year":"2014","journal-title":"Nutr J"},{"key":"2024103011391113500_CIT0108","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1053\/j.gastro.2018.12.002","article-title":"Treatment of active Crohn\u2019s disease with an ordinary food-based diet that replicates exclusive enteral nutrition","volume":"156","author":"Svolos","year":"2019","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ecco-jcc\/jjac135","article-title":"Paediatric inflammatory bowel disease: a multi-stakeholder perspective to improve development of drugs for children and adolescents","volume":"17","author":"Croft","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/apt.15094","article-title":"Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood","volume":"49","author":"Ashton","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0111","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/1744666X.2023.2231148","article-title":"Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease","volume":"19","author":"Smith","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"2024103011391113500_CIT0112","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1053\/j.gastro.2021.02.068","article-title":"Randomized controlled trial: subcutaneous vs intravenous infliximab CT-P13 maintenance in inflammatory bowel disease","volume":"160","author":"Schreiber","year":"2021","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MPG.0000000000003838","article-title":"Effectiveness of switching to subcutaneous infliximab in pediatric inflammatory bowel disease patients on intravenous maintenance therapy","volume":"77","author":"Gianolio","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0114","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.cgh.2022.08.011","article-title":"Effectiveness of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel diseases: the REMSWITCH Study","volume":"21","author":"Buisson","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0115","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"2024103011391113500_CIT0116","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MPG.0000000000002631","article-title":"Pharmacokinetics, pharmacodynamics, and immunogenicity of infliximab in pediatric inflammatory bowel disease: a systematic review and revised dosing considerations","volume":"70","author":"Winter","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/apt.15054","article-title":"The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn\u2019s disease: a post hoc analysis","volume":"49","author":"Hyams","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0118","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/ibd\/izz294","article-title":"Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn\u2019s disease: a post hoc analysis of the PAILOT randomized controlled trial","volume":"26","author":"Matar","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0119","doi-asserted-by":"crossref","first-page":"3190548","DOI":"10.1155\/2018\/3190548","article-title":"The continental divide: anti-TNF use in pediatric IBD is different in North America compared to other parts of the world","volume":"2018","author":"Church","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0120","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1053\/j.gastro.2017.02.004","article-title":"Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease","volume":"152","author":"Hyams","year":"2017","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0121","doi-asserted-by":"crossref","first-page":"izae060","DOI":"10.1093\/ibd\/izae060","article-title":"Infliximab monotherapy vs combination therapy for pediatric Crohn\u2019s disease exhibit similar pharmacokinetics","author":"Colman","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0122","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MPG.0000000000003366","article-title":"Long-term outcomes with adalimumab therapy in pediatric Crohn disease: associations with adalimumab exposure","volume":"74","author":"Rinawi","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0123","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.gtc.2023.05.002","article-title":"The role of therapeutic drug monitoring in children","volume":"52","author":"Nasr","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"key":"2024103011391113500_CIT0124","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/j.gastro.2019.06.003","article-title":"Proactive monitoring of adalimumab trough concentration associated with increased clinical remission in children with Crohn\u2019s disease compared with reactive monitoring","volume":"157","author":"Assa","year":"2019","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ibd\/izaa102","article-title":"Effect of a practice-wide anti-TNF proactive therapeutic drug monitoring program on outcomes in pediatric patients with inflammatory bowel disease","volume":"27","author":"Lyles","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0126","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MPG.0000000000002440","article-title":"Management of anti-drug antibodies to biologic medications in children with inflammatory bowel disease","volume":"69","author":"Cohen","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0127","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ibd\/izaa108","article-title":"Favorable outcomes and anti-TNF durability after addition of an immunomodulator for anti-drug antibodies in pediatric IBD patients","volume":"27","author":"Colman","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gut.2009.187120","article-title":"Early Crohn disease: a proposed definition for use in disease-modification trials","volume":"59","author":"Peyrin-Biroulet","year":"2010","journal-title":"Gut"},{"key":"2024103011391113500_CIT0129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/apt.15685","article-title":"Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn\u2019s disease","volume":"51","author":"Ungaro","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2020-322339","article-title":"First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn\u2019s disease: an open-label multicentre randomised controlled trial","volume":"71","author":"Jongsma","year":"2022","journal-title":"Gut"},{"key":"2024103011391113500_CIT0131","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ecco-jcc\/jjad197","article-title":"Improved clinical outcomes with early anti-tumour necrosis factor alpha therapy in children with newly diagnosed Crohn\u2019s disease: real world data from the international prospective PIBD-SETQuality inception cohort study","volume":"18","author":"Klomberg","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0132","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.gtc.2023.05.006","article-title":"Choosing the right therapy at the right time for pediatric inflammatory bowel disease: does sequence matter","volume":"52","author":"Spencer","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"key":"2024103011391113500_CIT0133","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5223\/pghn.2020.23.2.121","article-title":"Long-term efficacy of anti-tumor necrosis factor agents in pediatric luminal Crohn\u2019s disease: a systematic review of real-world evidence studies","volume":"23","author":"van Rheenen","year":"2020","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"2024103011391113500_CIT0134","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40272-023-00586-7","article-title":"Effectiveness and safety of ustekinumab for pediatric inflammatory bowel disease: a systematic review","volume":"25","author":"Fang","year":"2023","journal-title":"Paediatr Drugs"},{"key":"2024103011391113500_CIT0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12887-022-03229-x","article-title":"Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review","volume":"22","author":"Fang","year":"2022","journal-title":"BMC Pediatr"},{"key":"2024103011391113500_CIT0136","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2468-1253(22)00307-7","article-title":"Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study","volume":"8","author":"Atia","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0137","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1053\/j.gastro.2018.01.043","article-title":"Pharmacokinetics and exposure response relationships of ustekinumab in patients with Crohn\u2019s disease","volume":"154","author":"Adedokun","year":"2018","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0138","first-page":"1455","article-title":"Deciphering the vedolizumab dosing conundrum in IBD: when less is more","volume":"71","author":"Adolph","year":"2022","journal-title":"Gut"},{"key":"2024103011391113500_CIT0139","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/ecco-jcc\/jjac036","article-title":"Pharmacokinetics, safety and efficacy of intravenous vedolizumab in paediatric patients with ulcerative colitis or Crohn\u2019s disease: results from the phase 2 HUBBLE study","volume":"16","author":"Hyams","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/apt.17277","article-title":"Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance","volume":"57","author":"Colman","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011391113500_CIT0141","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/MPG.0000000000003616","article-title":"Tofacitinib salvage therapy for children hospitalized for corticosteroid-and biologic-refractory ulcerative colitis","volume":"75","author":"Constant","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0142","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/MPG.0000000000003190","article-title":"Tofacitinib therapy in children and young adults with pediatric-onset medically refractory inflammatory bowel disease","volume":"73","author":"Moore","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0143","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/PG9.0000000000000332","article-title":"Outcomes of tofacitinib use in an Irish pediatric cohort","volume":"4","author":"Ryan","year":"2023","journal-title":"JPGN reports"},{"key":"2024103011391113500_CIT0144","doi-asserted-by":"crossref","first-page":"e934460","DOI":"10.12659\/AJCR.934460","article-title":"Tofacitinib for a child with refractory steroid-dependent ulcerative colitis: a case report and review of the literature","volume":"22","author":"Alajmi","year":"2021","journal-title":"The Am J Case Rep"},{"key":"2024103011391113500_CIT0145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jcag\/gwad042","article-title":"The role of tofacitinib in the treatment of acute severe colitis in children","volume":"7","author":"Costaguta","year":"2024","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"2024103011391113500_CIT0146","doi-asserted-by":"crossref","first-page":"izad300","DOI":"10.1093\/ibd\/izad300","article-title":"Single-center experience with upadacitinib for adolescents with refractory inflammatory bowel disease","author":"Spencer","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0147","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40272-023-00579-6","article-title":"Dual-targeted therapy in pediatric inflammatory bowel disease: a comprehensive review","volume":"25","author":"Yerushalmy-Feler","year":"2023","journal-title":"Paediatr Drugs"},{"key":"2024103011391113500_CIT0148","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ibd\/izad064","article-title":"Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): a multicenter study from the pediatric IBD Porto Group of ESPGHAN","volume":"30","author":"Yerushalmy-Feler","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0149","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.gtc.2023.06.001","article-title":"When and where should surgery be positioned in pediatric inflammatory bowel disease","volume":"52","author":"Lipskar","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"key":"2024103011391113500_CIT0150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/archdischild-2013-305214","article-title":"Surgery for children with Crohn\u2019s disease: indications, complications and outcome","volume":"99","author":"Blackburn","year":"2014","journal-title":"Arch Dis Child"},{"key":"2024103011391113500_CIT0151","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpedsurg.2015.10.077","article-title":"Colectomy in pediatric ulcerative colitis: a single center experience of indications, outcomes, and complications","volume":"51","author":"Ashton","year":"2016","journal-title":"J Pediatr Surg"},{"key":"2024103011391113500_CIT0152","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/MEG.0000000000001197","article-title":"Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland","volume":"30","author":"Guilcher","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0153","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/MPG.0000000000001562","article-title":"Surgical management of Crohn disease in children: guidelines from the paediatric IBD Porto Group of ESPGHAN","volume":"64","author":"Amil-Dias","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0154","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2023.05.051","article-title":"Early ileocecal resection for Crohn\u2019s disease is associated with improved long-term outcomes compared with anti-tumor necrosis factor therapy: a population-based cohort study","volume":"165","author":"Agrawal","year":"2023","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0155","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: a randomised controlled, open-label, multicentre trial","volume":"2","author":"Ponsioen","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0156","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.MIB.0000194182.85047.6a","article-title":"Educate, communicate, anticipate-practical recommendations for transitioning adolescents with IBD to adult health care","volume":"12","author":"Hait","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0157","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/MIB.0000000000000045","article-title":"Transition of the patient with IBD from pediatric to adult care-an assessment of current evidence","volume":"20","author":"de Silva","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0158","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MPG.0000000000003581","article-title":"Outcomes in patients with inflammatory bowel disease transitioning from pediatric to adult care: a scoping review","volume":"75","author":"Bihari","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0159","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ecco-jcc\/jjx010","article-title":"European Crohn\u2019s and Colitis Organisation topical review on transitional care in inflammatory bowel disease","volume":"11","author":"van Rheenen","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0160","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ecco-jcc\/jjz044","article-title":"Health care transition outcomes in inflammatory bowel disease: a Multinational Delphi Study","volume":"13","author":"van den Brink","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0161","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2431-14-4","article-title":"A systematic review of the psychometric properties of transition readiness assessment tools in adolescents with chronic disease","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Pediatr"},{"key":"2024103011391113500_CIT0162","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jpepsy\/jsp128","article-title":"Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ\u2013Transition Readiness Assessment Questionnaire","volume":"36","author":"Sawicki","year":"2011","journal-title":"J Pediatr Psychol"},{"key":"2024103011391113500_CIT0163","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MPG.0000000000003868","article-title":"Validation and reference scores of the transition readiness assessment questionnaire in adolescent and young adult IBD patients","volume":"77","author":"van Gaalen","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0164","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ibd\/izz074","article-title":"Challenges in IBD research","volume":"25","author":"Andr\u00e9s Hurtado-Lorenzo","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0165","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S2468-1253(23)00140-1","article-title":"The top 10 research priorities for inflammatory bowel disease in children and young adults: results of a James Lind Alliance Priority Setting Partnership","volume":"8","author":"Jagt","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0166","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ibd\/izz075","article-title":"Challenges in IBD research: preclinical human IBD mechanisms","volume":"25","author":"Pizarro","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0167","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/ibd\/izz078","article-title":"Challenges in IBD research: precision medicine","volume":"25","author":"Denson","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011391113500_CIT0168","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nature Rev Methods Primers"},{"key":"2024103011391113500_CIT0169","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmgh.2017.12.010","article-title":"Microfluidic organ-on-a-chip models of human intestine","volume":"5","author":"Bein","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0170","doi-asserted-by":"crossref","first-page":"21475","DOI":"10.1038\/s41598-020-78359-2","article-title":"Development of a human primary gut-on-a-chip to model inflammatory processes","volume":"10","author":"Beaurivage","year":"2020","journal-title":"Sci Rep"},{"key":"2024103011391113500_CIT0171","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.gastro.2020.07.066","article-title":"Predicting outcomes in pediatric ulcerative colitis for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease\u2013ahead program","volume":"160","author":"Orlanski-Meyer","year":"2021","journal-title":"Gastroenterology"},{"key":"2024103011391113500_CIT0172","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrgastro.2017.110","article-title":"The IBD interactome: an integrated view of aetiology, pathogenesis and therapy","volume":"14","author":"de Souza","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0173","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.3390\/ijms241914912","article-title":"Omics and multi-omics in IBD: no integration, no breakthroughs","volume":"24","author":"Fiocchi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024103011391113500_CIT0174","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/ecco-jcc\/jjab051","article-title":"Results of the Seventh Scientific Workshop of ECCO: precision medicine in IBD \u2013 what, why, and how","volume":"15","author":"Fiocchi","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0175","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ecco-jcc\/jjac005","article-title":"Existing prediction models of disease course in paediatric Crohn\u2019s disease are poorly replicated in a prospective inception cohort","volume":"16","author":"Atia","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0176","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/ecco-jcc\/jjz085","article-title":"Diagnostic accuracy of transabdominal ultrasound in detecting intestinal inflammation in paediatric IBD patients-a systematic review","volume":"13","author":"van Wassenaer","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2024103011391113500_CIT0177","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MPG.0000000000003649","article-title":"Intestinal ultrasound for the pediatric gastroenterologist: a guide for inflammatory bowel disease monitoring in children: expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric Committee","volume":"76","author":"Kellar","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0178","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jpn3.12098","article-title":"Diagnostic accuracy of multimodal noninvasive follow-up for pediatric ulcerative colitis: a single-center prospective study","volume":"78","author":"Spyropoulou","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0179","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3748\/wjg.v25.i5.632","article-title":"Fatigue in children and adolescents with inflammatory bowel disease","volume":"25","author":"Van de Vijver","year":"2019","journal-title":"World J Gastroenterol"},{"key":"2024103011391113500_CIT0180","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cgh.2009.01.022","article-title":"Fatigue and health-related quality of life in pediatric inflammatory bowel disease","volume":"7","author":"Marcus","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011391113500_CIT0181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0259-2","article-title":"Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses","volume":"13","author":"Morris","year":"2015","journal-title":"BMC Med"},{"key":"2024103011391113500_CIT0182","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MPG.0000000000003816","article-title":"Physical training and healthy diet improved bowel symptoms, quality of life and fatigue in children with inflammatory bowel disease","volume":"77","author":"Scheffers","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011391113500_CIT0183","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/cpt.2736","article-title":"Off-label, but on-evidence? A review of the level of evidence for pediatric pharmacotherapy","volume":"112","author":"van der Zanden","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"2024103011391113500_CIT0184","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPG.0000000000001024","article-title":"Use of placebo in pediatric inflammatory bowel diseases: a position paper from ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network","volume":"62","author":"Turner","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/18\/Supplement_2\/ii31\/60195084\/jjae087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/18\/Supplement_2\/ii31\/60195084\/jjae087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T11:49:41Z","timestamp":1732189781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/18\/Supplement_2\/ii31\/7848695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":184,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2024,10,30]]},"published-print":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae087","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,10]]}}}